About
Stefan Irion is a regenerative-medicine executive and physician-scientist focused on pluripotent stem cell and cell-therapy development. Search-result coverage shows GC Therapeutics appointed him Chief Scientific Officer on May 5, 2026 after prior leadership roles at BlueRock Therapeutics, where he was publicly described in 2023 as Senior Vice President of Research and later appeared as Chief Scientific Officer in company materials. He is also publicly visible in the stem-cell research community through ISSCR programming related to PSC-derived therapies.
Areas of interest
biotechregenerative medicinestem cellscell therapyiPSC-derived therapiesParkinson's diseasetranslational medicine